Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 2
2003 1
2007 1
2017 1
2020 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Sims JR, et al. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. JAMA. 2023. PMID: 37459141 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial.
Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators. Teng E, et al. JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375. JAMA Neurol. 2022. PMID: 35696185 Free PMC article. Clinical Trial.
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet.
Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R, Sanabria Bohorquez SM, Anania VG, Wildsmith KR, Schauer SP, Lee J, Dolton MJ, Ramakrishnan V, Abramzon D, Teng E; Lauriet investigators. Monteiro C, et al. Neurology. 2023 Oct 3;101(14):e1391-e1401. doi: 10.1212/WNL.0000000000207663. Epub 2023 Aug 29. Neurology. 2023. PMID: 37643887 Free PMC article. Clinical Trial.
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
Vossler DG, Knake S, O'Brien TJ, Watanabe M, Brock M, Steiniger-Brach B, Williams P, Roebling R; SP0982 co-investigators. Vossler DG, et al. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1067-1075. doi: 10.1136/jnnp-2020-323524. Epub 2020 Aug 18. J Neurol Neurosurg Psychiatry. 2020. PMID: 32817358 Free PMC article. Clinical Trial.
Mechanical thrombectomy in acute stroke - Five years of experience in Poland.
Polish Thrombectomy Initiative; Słowik A, Wnuk M, Brzegowy P, Chrzanowska-Waśko J, Golenia A, Łasocha B, Włoch-Kopeć D, Ferens A, Serednicki W, Jarocki P, Bartosik-Psujek H, Kaczorowski R, Filip E, Grzegorzak M, Homa J, Darocha J, Dudek D, Guz W, Rejdak K, Luchowski P, Wojczal J, Sojka M, Górnik M, Stachowicz S, Jaworski J, Buraczyńska K, Ficek R, Szczepańska-Szerej A, Jargiełło T, Szczerbo-Trojanowska M, Lasek-Bal A, Puz P, Warsz-Wianecka A, Stęposz A, Ziaja K, Kuczmik W, Urbanek T, Ziaja D, Tomalski W, Kobayashi A, Richter P, Płoński A, Kotkowski M, Czepiel W, Kurkowska-Jastrzębska I, Sienkiewicz-Jarosz H, Członkowska A, BłażejewskaHyżorek B, Ryglewicz D, Konopko M, Brelak E, Antecki J, Szydłowski I, Włosek M, Stępień A, Brzozowski K, Staszewski J, Piasecki P, Zięcina P, Wołoszyńska I, Kolmaga N, Narloch J, Hasiec T, Gawłowicz J, Pędracka M, Porębiak J, Grzechnik B, Matsibora V, Frąszczak M, Leus M, Mazgaj M, Palacz-Duda V, Meder G, Skura W, Płeszka P, Świtońska M, Słomiński K, Kościelniak J, Sobieszak-Skura P, Konieczna-Brazis M, Rowiński O, Opuchlik A, Mickielewicz A, Szyluk B, Szczudlik P, Kostera-Pruszczyk A, Jaworski M, Maciąg R, Żyłkowski J, Adamkiewicz B, Szubert W… See abstract for full author list ➔ Polish Thrombectomy Initiative, et al. Among authors: mickielewicz a. Neurol Neurochir Pol. 2017 Sep-Oct;51(5):339-346. doi: 10.1016/j.pjnns.2017.05.004. Epub 2017 Jul 5. Neurol Neurochir Pol. 2017. PMID: 28756015
Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.
Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schröder W, Herrmann FH, Jedrzejowska H. Lopaciuk S, et al. Among authors: mickielewicz a. Clin Appl Thromb Hemost. 2001 Oct;7(4):346-50. doi: 10.1177/107602960100700418. Clin Appl Thromb Hemost. 2001. PMID: 11697722 Free article.
12 results